Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy

References

• Weller M. K., Heimann P., Wiedemann P. Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy. Int. Ophthalmol. 1988; 11: 181–186
   PubMed Web of Science ®Google Scholar
• Charteris D. G., Hiscott P., Grierson I., Lightman S. Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology 1992; 99: 1364–1367
   PubMed Web of Science ®Google Scholar
• Scheiffarth O. F., Tang S., Kampik A. Macrophages and HLA-DR expression in proliferative vitreoretinopathy. Fortschr. Ophthalmol. 1990; 87: 340–343
   PubMedGoogle Scholar
• Killingsworth M. C., Sarks J. P., Sarks S. H. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990; 4: 613–621
   PubMed Web of Science ®Google Scholar
• Lopez P. p., Grossniklaus H. E., Lambert H. M., Aaberg T. M., Capone A., Jr, Sternberg P., Jr, L'Hernault N. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am. J. Ophthalmol. 1991; 112: 647–656
   PubMed Web of Science ®Google Scholar
• Kampik A., Kenyon K. R., Michels R. G., Green W. R., de la Cruz Z. C. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch. Ophthalmol. 1981; 99: 1445–1454
   PubMed Web of Science ®Google Scholar
• Vinore S. A., Campochiaro P. A., Conway B. P. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest. Ophthalmol. Vis. Sci. 1990; 31: 14–28
   PubMedGoogle Scholar
• Kovacs E. J., DiPietro L. A. Fibrogenic cytokines and connective tissue production. FASEB 1994; 8: 854–861
   PubMed Web of Science ®Google Scholar
• Larsen C. G., Anderson A. O., Apella E., Oppenheim J. J., Matsushma K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464–1466
   PubMed Web of Science ®Google Scholar
• Thelen M., Peveri P., Kernen P., von Tscharner V., Walz A., Baggiolini M. Mechanisms of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB 1988; 2: 2702–2706
   PubMed Web of Science ®Google Scholar
• Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 1994; 55: 97–179
   PubMed Web of Science ®Google Scholar
• Zwahlen R., Walz A., Rot A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int. Rev. Exp. Pathol. 1993; 34B: 27–42
   Google Scholar
• Strieter R. M., Kunkel S. L., Elner V. M., Martonyi C. L., Koch A. E., Polverini P. J., Elner S. G. Interleukin-8: A corneal factor that induces neovascularization. Am. J. Pathol. 1992; 141: 1279–84
   PubMed Web of Science ®Google Scholar
• Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., DiPietro L. A., Elner V. M., Elner S. G., Strieter R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798–1801
   PubMed Web of Science ®Google Scholar
• Matsushima K., Larsen C. G., DuBois G. C., Oppenheim J. J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 1989; 169: 1485–1490
   PubMed Web of Science ®Google Scholar
• Rollins B. J., Walz A., Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991; 78: 1112–1116
   PubMed Web of Science ®Google Scholar
• Tushinski R. J., Oliver I. T., Guilbert L. J., Tynan P. W., Warner J. R., Stanley E. R. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 1982; 28: 71–81
   PubMed Web of Science ®Google Scholar
• Wang J. M., Griffin J. D., Rambaldi A., Chen Z. G., Mantovani A. Induction of monocyte migration by recombinant macrophage colony-stimulating factory. J. Immunol. 1988; 141: 57–79
   Web of Science ®Google Scholar
• Cheers C., Hill M., Haigh A. M., Stanley E. R. Stimulation of macrophage phagocytic but not bactericidal activity by colony-stimulating factor 1. Infect. Immunol. 1989; 57: 1512–1516
   PubMed Web of Science ®Google Scholar
• Ralph P., Warren M. K., Nakoinz I., Lee M. T., Brindley L., Sampson-Johannes A., Kawasaki E. S., Ladner U. B., Strickler J. E., Boosman A., Csejtey J., White T. J. Biological properties and molecular biology of the human macrophage growth factor, CSF-1. Immuno-biology 1986; 172: 194–204
   PubMedGoogle Scholar
• Ralph P., Ladner M. B., Wang A. M., Kawaski E. S., McConlogue L., Weaver J. F., Weiss S. A., Shadle P., Koths K., Warren M. K., Stanley E. R., Broxmeyer H. E. The molecular and biological properties of the human and murine members of the CSF-1 family. Molecular Basis of Lymphokine Action, D. R. Webb, C. W. Pierce, S. Cohen. Humana Press Inc, Clifton, NJ 1987; 295–311
   Google Scholar
• Elner V. M., Strieter R. M., Elner S. G., Baggiolini M., Lindley I., Kunkel S. L. Neutrophil chemotactic factor (IL-8) gene expression by cytokine treated retinal pigment epithelial cells. Am. J. Pathol. 1990; 136: 745–750
   PubMed Web of Science ®Google Scholar
• Elner S. G., Strieter R. M., Elner V. M., Rollins B. J., Del Monte M. A., Kunkel S. K. Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab. Invest. 1991; 64: 819–825
   PubMed Web of Science ®Google Scholar
• Jaffe G. J., Peters W. P., Roberts W., Kurtzberg J., Stuart A., Wang A. M., Stoudemire J. B. Modulation of macrophage colony stimulating factor in cultured human retinal pigment epithelial cells. Exp. Eye. Res. 1992; 54: 595–603
   PubMed Web of Science ®Google Scholar
• The Retina Society Terminology Committtee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983; 90: 121–125
   PubMedGoogle Scholar
• Evanoff H. L., Burdick M. D., Moore S. A., Kunkel S. L., Strieter R. M. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 1992; 21: 39–45
   PubMed Web of Science ®Google Scholar
• Strieter R. M., Wiggins R., Phan S. H., Wharram B. L., Showel H. J., Remick D. G., Chensue S. W., Kunkel S. L. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem. Biophys. Res. Comm. 1989; 162: 694–700
   PubMed Web of Science ®Google Scholar
• deBoer J. H., Hack C. E., Verhoeven A. J., Baarsma G. S., Paulus T. V., dejong P. T., Rademakers A. J., deVries-Knoppert W. A., Rothova A., Kijlstra A. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest. Ophthalmol. Vis. Sci. 1993; 34: 3376–3385
   PubMedGoogle Scholar
• Kauffmann D. J. H., van Meurs J. C., Mertens D. A. E., Perperkamp E., Master C., Gerritsen M. E. Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 1994; 35: 900–906
   PubMed Web of Science ®Google Scholar
• Limb G. A., Little B. C., Meager A., Ogilvie J. A., Wolstencroft R. A., Franks W. A., Chignell A. H., Dumonde D. C. Cytokines in proliferative vitreoretinopathy. Eye 1991; 5: 686–693
   PubMedGoogle Scholar
• Abu El Asrar A. M., Maimone D., Morse P. H., Gregory S., Reder A. T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 1992; 114: 731–736
   PubMed Web of Science ®Google Scholar
• Tang S., Scheiffarth O. F., Thurau S. R., Wildner G. Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmic. Res. 1993; 25: 177–185
   PubMed Web of Science ®Google Scholar
• Limb G. A., Alam A., Earley O., Green W., Chignell A. H., Dumonde D. C. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr. Eye. Res. 1994; 13: 791–798
   PubMed Web of Science ®Google Scholar
• Elner S. G., Elner V. M., Puro D., Strieter R. M., Kunkel S. L. Interleukin-8 and monocyte chemotactic protein-1 production by human Mueller cells. (Abstract). Invest. Ophthalmol. Vis. Sci 1995; 36(Suppl.)256
   Google Scholar
• Strieter R. M., Kunkel S. L., Showell H. J., Remick D. G., Phan S. H., Ward P. A., Marks R. M. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 1989; 243: 1467–1469
   PubMed Web of Science ®Google Scholar
• Strieter R. M., Phan S. H., Showell H. J., Remick D. G., Lynch J. P., Genord M., Raiford C., Eskandari M., Marks R. M., Kunkel S. L. Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J. Biol. Chem. 1989; 264: 10621–10626
   PubMed Web of Science ®Google Scholar
• Kawano Y., Takaue Y., Motoyoshi K., Minakuchi J., Kawashima S., Saito S., Hirao A., Sato J., Shimizu T., Kuroda Y. Measurement of serum levels of macrophage colony-stimulating factor (M-CSF) in patients with uremia. Exp. Hematol. 1993; 21: 220–223
   PubMedGoogle Scholar
• Itoh Y., Okanoue T., Enjyo F., Sakamoto S., Ohmoto Y., Hirai Y., Kagawa K., Kashima K. Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease. J. Hepatol. 1994; 21: 527–535
   PubMedGoogle Scholar
• Elg S. A., Yu Y., Carson L. F., Adcock L. L., Twiggs L. B., Prem K. A., Ramakrishnansi S. Serum levels of macrophage colony-stimulating factor in patients with ovarian cancer undergoing second-look laparotomy. Am. J. Obstet. Gynecol. 1992; 166: 134–137
   PubMedGoogle Scholar
• Praloran V., Coupey L., Donnard M., Berrada L., Naud M. F. Elevation of serum M-CSF concentrations during pregnancy and ovarian hyper-stimulation. Br. J. Haematol. 1994; 86: 675–677
   PubMedGoogle Scholar
• Ham J. M., Kunkel S. L., Dibb C. R., Standiford T. J., Rolfe M. W., Strieter R. M. Chemotactic cytokine (IL-8 and MCP-1) gene expression by human whole blood. Immunol. Invest. 1991; 20: 387–394
   PubMed Web of Science ®Google Scholar
• Sylvester I., Suffredini A. F., Boujoukos A. J., Martich G. D., Danner R. L., Yoshimura T., Leonard E. J. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. J. Immunol. 1993; 151: 3292–3298
   PubMedGoogle Scholar
• Ham J. M., Kunkel S. L., Dibb C. R., Standiford T. J., Rolfe M. W., Strieter R. M. Chemotactic cytokine (IL-8 and MCP-1) gene expression by human whole blood. Immunol. Invest. 1991; 20: 387–394
   PubMed Web of Science ®Google Scholar
• Sylvester I., Yoshimura T., Sticherling M., Schroder J., Ceska M., Peichl P., Leonard L. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J. Clin. Invest. 1992; 90: 471–481
   PubMed Web of Science ®Google Scholar
• Halstensen A., Ceska M., Brandtzaeg P., Redl H., Naess A., Waage A. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 1993; 167: 471–475
   PubMed Web of Science ®Google Scholar
• Brauner A., Hylander B., Wretlind B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am. J. Kidney. Dis. 1993; 122: 430–435
   Google Scholar
• Matsumoto T., Miike T., Nelson R. P., Trudeau W. L., Lockey R. F., Yodo J. Elevated serum levels of IL-8 in patients with HIV infection. Clin. Exp. Immunol. 1993; 93: 149–151
   PubMed Web of Science ®Google Scholar
• Reitamo S., Remitz A., Varga J., Ceska M., Effenberger F., Jimenez S., Utto J. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders. Arch. Dermatol. 1993; 129: 189–93
   PubMedGoogle Scholar
• de Vos A. F., Hoekzema R., Kijlstra A. Cytokines and uveitis, a review. Curr. Eye. Res. 1992; 11: 581–597
   PubMed Web of Science ®Google Scholar
• Hooks J. J., Chan C. C., Detrick B. Identification of lymphokines, interferon-gamma, and interleukin-2 in inflammatory eye disease. Invest. Ophthalmol. Vis. Sci. 1988; 29: 1444–1451
   PubMed Web of Science ®Google Scholar
• Murray P. I., Hoekzema R., van Haren M. A., de Hon F. D., Kijlstra A. Aqueous humour interleukin 6 levels in uveitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 917–920
   PubMed Web of Science ®Google Scholar
• Ferrick M. R., Thurau S. R., Oppenheim M. H., Herbort C. P., Ni M., Zachariae C. O., Matsushima K., Chan C. C. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest. Ophthalmol. Vis. Sci. 1991; 32: 1534–1539
   PubMed Web of Science ®Google Scholar
• Rosenbaum J. T., Samples J. R., Hefeneider S. H., Howes E. L. Ocular inflammatory effects of intravitreal interleukin 1. Arch. Ophthalmol. 1987; 105: 1117–1120
   PubMed Web of Science ®Google Scholar
• Rosenbaum J. T., Howes E. L., Rubin R. M., Samples J. R. Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. Am. J. Pathol. 1988; 133: 47–53
   PubMed Web of Science ®Google Scholar
• Issekutz A., Bhimji S. Role for endotoxin in the leukocyte infiltration accompanying E. coli inflammation. Infect. Immun. 1982; 36: 558–566
   PubMed Web of Science ®Google Scholar
• Yoshimura T., Matsushima K., Oppenheim J. J., Leonard E. J. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL-1). J. Immunol. 1987; 139: 788–793
   PubMed Web of Science ®Google Scholar
• Adamis A. P., Miller J. W., Bernal M. T., D'Amico D. J., Folkman J., Yeo T. K., Yeo K. T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 1994; 118: 445–450
   PubMed Web of Science ®Google Scholar
• Baudouin C., Fredj-Reygrobellet D. F., Brignole F., Negre F., Lapalus P., Gastaud P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic. Res. 1993; 25: 52–59
   PubMed Web of Science ®Google Scholar
• Forrester J. V., Shafiee A., Schroder S., Knott R., Mcintosh L. The role of growth factors in proliferative diabetic retinopathy. Eye 1993; 7: 276–287
   PubMedGoogle Scholar
• Limb G. A., Kapur S., Woon H., Franks W. A., Jones S. E., Chignell A. H. Expression of mRNA for interleukin 6 by cells infiltrating epiretinal membranes in proliferative vitreoretinopathy. (Abstract) Agents Actions, Special Conference Issue 1993; 38(Suppl.)C73–C75
   Google Scholar
• Patel B., Hiscott P., Charteris D., Mather J., McLeod D., Boulton M. Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Brit. J. Ophthalmol. 1994; 78: 714–718
   PubMed Web of Science ®Google Scholar
• Wiedemann P. Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv. Ophthalmol. 1992; 36: 373–384
   PubMed Web of Science ®Google Scholar
• Kauffman D. J. H., Rimarachin J. A., Partridge C. A., Gerritsen M. E. Neutrophil chemoattractant activity in vitreous from patients with proliferative vitreoretinopathy and severe diabetic retinopathy. (Abstract). Invest. Ophthalmol. Vis. Sci 1989; 30(Suppl)11
   Google Scholar
• Connor T. B., Jr, Roberts A. B., Sporn M. B., Danielpour D., Dart L. L., Michels R. G., de Bustros S., Enger C., Kato H., Lansing M., Hayashi H., Glaser B. M. Correlation of fibrosis and transforming growth factor beta type 2 levels in the eye. J. Clin. Invest. 1989; 83: 1161–1166
   Google Scholar